Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults

Open access
Woodhouse, Linda J., Mukherjee, Annice, Shalet, Stephen M., Ezzat, Shereen·2006·Endocrine Reviews

Abstract

The availability of recombinant human GH and somatostatin analogs has resulted in widespread treatment for adults with GH deficiency (GHD) and those with GH excess (acromegaly).Despite being at opposite ends of the spectrum in terms of their GH/IGF-I axis, both of these populations experience overlapping somatic impairments.Adults with untreated GHD have low circulating levels of IGF-I that manifest as altered body composition with increased fat and reduced lean body and skeletal muscle mass.At the other end of the spectrum, adults with GH excess, who have elevated levels of IGF-I, also have altered body composition.Impairments that result from disorders of either GHD or GH excess are both associated with increased functional limitations, such as reduced ability to walk quickly for prolonged periods, and poorer health-related quality of life (HR-QoL).Adults with untreated GHD and GH excess both commonly complain of excessive fatigue that seems to be associated more with impaired aerobic than muscular performance.Several studies have documented that administration of GH or somatostatin analogs to adults with GHD or GH excess, respectively, ameliorates abnormal biochemical profile and the associated somatic impairments.However, whether these improvements translate into improved physical function in adults with GHD or GH excess remains largely unknown, and their impact on HR-QoL controversial.Review of placebocontrolled trials to date suggests that GH and somatostatin analogs have greater effects on gas exchange and aerobic performance than as anabolic agents on skeletal muscle mass and function.Future investigations should include dose-response studies to establish the optimal combination of pharmacological agents plus exercise required to improve not only biochemical markers but also physical function and HR-QoL in adults with GHD or GH excess.(Endocrine Reviews 27: 287-317, 2006) I. Introduction II.Physical Impairments A. Effects of GH/IGF-I on myogenic differentiation B. In vitro effects of GH/IGF-I on differentiated skeletal muscle C. In vivo effects of GH/IGF-I status on differentiated skeletal muscle: animal studies D. In vivo effects of GH/IGF-I status on differentiated skeletal muscle: human studies E. Effects of GH/IGF-I status on protein metabolism F. Effects of GH/IGF-I status on lean body mass G. Effects of GH/IGF-I status on skeletal muscle performance H. Effects of GH/IGF-I status on aerobic performance III.Functional Limitations A. Effects of GH/IGF-I status on physical function IV.Health-Related Quality of Life A. Effects of GH/IGF-I status on health-related quality of life V. Summary and Conclusions

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2004-0022

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 195

Metadata

Authors
Woodhouse, L. J., Mukherjee, A., Shalet, S. M., & Ezzat, S.
Venue
Endocrine Reviews
Published
2006-05-01
Volume
27
Issue
3
Pages
287-317
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2137300166
Cited by
195
References
10
FWCI
11.09
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults. https://app.cochat.ai/papers/10.1210/er.2004-0022
The paper
Woodhouse, L. J., Mukherjee, A., Shalet, S. M., & Ezzat, S. (2006). The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults. Endocrine Reviews. https://doi.org/10.1210/er.2004-0022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.